PLATINUM Diversity
Increasing Diversity in Clinical Trials with PLATINUM Diversity: Outcomes with the Promus PREMIER™ Stent in Women and Minorities
PLATINUM Diversity is a first-of-its-kind study focused solely on women and minorities, groups that are less likely to be included in cardiology studies. The study will help health care providers understand how a variety of factors affect patient outcomes one year after a stent is implanted. These factors include income, marital status, education, living/working conditions, access to and use of health care, and language agreement.
The study found that women and minority men are at increased risk of cardiac events compared to white men. Risk factors for heart disease such as diabetes and hypertension were higher in women and minority men than in white men. Where income was reported, there appeared to be a relationship between higher incomes and lower risk of death, myocardial infarction (MI) and target vessel revascularization (TVR).
The PLATINUM Diversity Study is an example of Boston Scientific’s commitment to promoting health equity, raising awareness and increasing access to health care. It is aligned with Close the Gap’s mission to eliminate cardiovascular care disparities, and to improve health service access to all patients, regardless of age, gender, race, ethnicity or primary language.